Dr. Jaime J. Vanourny, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Iowa, Rj & L Carver College of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 848
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: University of Iowa, Rj & L Carver College of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
NC license 201101796 · IA license R8536
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Piedmont Plastic Surgery and Dermatology PA (56 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 848
- Services billed
- 5,015
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,558 | 294 |
| Established patient office or other outpatient visit, 20-29 minutes | 877 | 671 |
| Destruction of precancer skin growth, 1 growth | 560 | 410 |
| Biopsy of related skin growth, first growth | 401 | 345 |
| Destruction of skin growth, 1-14 growths | 233 | 190 |
| Biopsy of related skin growth, each additional growth | 165 | 118 |
| Established patient office or other outpatient visit, 10-19 minutes | 82 | 76 |
| Established patient office or other outpatient visit, 30-39 minutes | 79 | 58 |
| New patient office or other outpatient visit, 30-44 minutes | 74 | 74 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 72 | 68 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ketoconazole Other prescribers in Gastonia, NC | 160 |
| Triamcinolone Acetonide Other prescribers in Gastonia, NC | 108 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Gastonia, NC | 74 |
| Fluorouracil Other prescribers in Gastonia, NC | 69 |
| Mupirocin Other prescribers in Gastonia, NC | 65 |
| Nystatin Other prescribers in Gastonia, NC | 61 |
| Metronidazole Other prescribers in Gastonia, NC | 53 |
| Clobetasol Propionate Other prescribers in Gastonia, NC | 50 |
| Imiquimod | 34 |
| Doxycycline Hyclate Other prescribers in Gastonia, NC | 33 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 123 payments worth $2,032 in total to this clinician.
| UCB, Inc. | $395 |
|---|---|
| Incyte Corporation | $289 |
| Pfizer Inc. | $264 |
| AbbVie Inc. | $246 |
| Regeneron Healthcare Solutions, Inc. | $143 |
| Galderma Laboratories, L.P. | $141 |
| Sun Pharmaceutical Industries Inc. | $135 |
| Leo Pharma Inc. | $108 |
| Food and Beverage | $2,032 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $956 in research payments for these studies, mostly to the institutions running them.
- Observational Evaluation of Atopic Dermatitis in Pediatric Patients
Sanofi US Services Inc. · Active, not recruiting · NCT03687359
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.